Amazon has agreed to pay $2.5 billion to settle allegations brought by the Federal Trade Commission over how it enrolled customers in Prime and how difficult it made cancellation. The FTC alleged ...

Editor’s Note: New Prime Video subscribers can enjoy a 30-day free trial period to see Prime Video’s extensive NASCAR race coverage, starting with the Coca-Cola 600 at Charlotte Motor Speedway on May ...

(NEXSTAR) – The second phase of a $2.5 billion settlement over Amazon Prime has begun, giving those who have not yet received a payment a chance to cash in. Last year, Amazon settled with the Federal ...

It’s a quiet month for dramas on Amazon Prime Video, even though a handful of big releases like Sinners will be making their debut on the streamer later in December. Since those new arrivals aren’t ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

It's the last month of the year, and Amazon is closing out 2025 with 14 free games for Prime members via Amazon Luna. One of the big highlights this month is Lego 2K Drive, an open-world racing game ...

“Fallout” Season 2 headlines this month’s streaming premieres for Amazon’s Prime Video. The sophomore season of the hit video game adaptation is set to make its long-awaited debut on the streaming ...

Amazon has started issuing payments to eligible Prime members as part of a $2.5 billion settlement over federal allegations that it misled customers. The online retailer agreed to the payouts in ...

Amazon has become one of the most ubiquitous retail brands in the United States, if not the world, shipping out scores of products with a fleet of branded vans and trucks. Prime membership is arguably ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...